YUNKANG GROUP (Stock Code: 02325) Expects Turnaround with Positive 2025 Net Profit

Bulletin Express03-06

YUNKANG GROUP (Stock Code: 02325) has released a positive profit alert, indicating an anticipated net profit ranging from RMB3.20 million to RMB9.80 million for the year ended December 31, 2025. In contrast, the group recorded a net loss of approximately RMB793.20 million for the year ended December 31, 2024.

According to the announcement, the turnaround primarily reflects targeted measures to optimize customer mix and product portfolio, as well as deeper cooperation within medical institution alliances, which has slowed the decline in overall revenue. Efforts to strengthen cost control and improve resource allocation have also led to lower selling and administrative expenses, while optimized debt structures reduced finance costs. Additionally, strengthened management of trade receivables contributed to better cash flow, with some previously recorded credit impairment losses reversed following successful debt recovery.

The announcement notes that the disclosed figures are based on draft unaudited consolidated management accounts, which remain subject to adjustments. The formal annual results announcement is expected to be published in March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157288424?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157288424","market":"hk","top_or_hot":-1,"title":"YUNKANG GROUP (Stock Code: 02325) Expects Turnaround with Positive 2025 Net Profit","media":"Bulletin Express","content":"<p>YUNKANG GROUP (Stock Code: 02325) has released a positive profit alert, indicating an anticipated net profit ranging from RMB3.20 million to RMB9.80 million for the year ended December 31, 2025. In contrast, the group recorded a net loss of approximately RMB793.20 million for the year ended December 31, 2024.</p>\n<p>According to the announcement, the turnaround primarily reflects targeted measures to optimize customer mix and product portfolio, as well as deeper cooperation within medical institution alliances, which has slowed the decline in overall revenue. Efforts to strengthen cost control and improve resource allocation have also led to lower selling and administrative expenses, while optimized debt structures reduced finance costs. Additionally, strengthened management of trade receivables contributed to better cash flow, with some previously recorded credit impairment losses reversed following successful debt recovery.</p>\n<p>The announcement notes that the disclosed figures are based on draft unaudited consolidated management accounts, which remain subject to adjustments. The formal annual results announcement is expected to be published in March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YUNKANG GROUP (Stock Code: 02325) Expects Turnaround with Positive 2025 Net Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYUNKANG GROUP (Stock Code: 02325) Expects Turnaround with Positive 2025 Net Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YUNKANG GROUP (Stock Code: 02325) has released a positive profit alert, indicating an anticipated net profit ranging from RMB3.20 million to RMB9.80 million for the year ended December 31, 2025. In contrast, the group recorded a net loss of approximately RMB793.20 million for the year ended December 31, 2024.</p>\n<p>According to the announcement, the turnaround primarily reflects targeted measures to optimize customer mix and product portfolio, as well as deeper cooperation within medical institution alliances, which has slowed the decline in overall revenue. Efforts to strengthen cost control and improve resource allocation have also led to lower selling and administrative expenses, while optimized debt structures reduced finance costs. Additionally, strengthened management of trade receivables contributed to better cash flow, with some previously recorded credit impairment losses reversed following successful debt recovery.</p>\n<p>The announcement notes that the disclosed figures are based on draft unaudited consolidated management accounts, which remain subject to adjustments. The formal annual results announcement is expected to be published in March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02325","symbol_name":"云康集团","start_time":0,"source_url":"","article_id":"1157288424","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157288424","pubTimestamp":1772800968,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"YUNKANG GROUP (Stock Code: 02325) has released a positive profit alert, indicating an anticipated net profit ranging from RMB3.20 million to RMB9.80 million for the year ended December 31, 2025. In...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02325":"云康集团"},"translate_title":"云康集团（股票代码：02325）预计扭亏为盈2025年净利润为正","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02325":1},"content_text":"YUNKANG GROUP (Stock Code: 02325) has released a positive profit alert, indicating an anticipated net profit ranging from RMB3.20 million to RMB9.80 million for the year ended December 31, 2025. In contrast, the group recorded a net loss of approximately RMB793.20 million for the year ended December 31, 2024.\nAccording to the announcement, the turnaround primarily reflects targeted measures to optimize customer mix and product portfolio, as well as deeper cooperation within medical institution alliances, which has slowed the decline in overall revenue. Efforts to strengthen cost control and improve resource allocation have also led to lower selling and administrative expenses, while optimized debt structures reduced finance costs. Additionally, strengthened management of trade receivables contributed to better cash flow, with some previously recorded credit impairment losses reversed following successful debt recovery.\nThe announcement notes that the disclosed figures are based on draft unaudited consolidated management accounts, which remain subject to adjustments. The formal annual results announcement is expected to be published in March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157288424","isCrawlerRequest":true}